Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pyrotinib by Jiangsu Hengrui Medicine for Breast Cancer: Likelihood of Approval
Pyrotinib is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Breast Cancer. According to GlobalData,...